Intra-Cellular Therapies, Inc.
ITCIDelisted Apr 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567514
Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.
Superinvestors holding ITCI, Q1 2025
1 superinvestor reports holding Intra-Cellular Therapies, Inc. on Form 13F, worth $15.4M in total. Weight is Intra-Cellular Therapies, Inc.'s share of each 13F portfolio; actions compare shares with Q4 2024.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Soros Fund ManagementGeorge Soros | 0.3% | 116,588 | $15.4M | New |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ITCI each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2025
1 superinvestor holding at quarter end
- New
- Soros Fund Management
- Sold out
- Maverick Capital
Q4 2024
1 superinvestor holding at quarter end
Q2 2024
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q1 2024
1 superinvestor holding at quarter end
Q2 2023
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q1 2023
1 superinvestor holding at quarter end
Q3 2021
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q2 2021
1 superinvestor holding at quarter end